Sort by: Latest openings
tallactherapeutics.com
tallactherapeutics.com • Burlingame, United States • 201-500 employees • Founded 2018 • Startup • New • Venture round $61.6M · 6 yr ago • Lightstone Ventures · venBio Partners
Hong Wan · Executive Officer, Director · decision-maker · no contact
Ran Geng · Director · no contact
Michael Carusi · Director · no contact
Jaume Pons · Director · no contact
No careers mailbox known
Follow
···
attralus.com
attralus.com • South San Francisco, United States +1 offices • Health Care • Biologics & Biosimilars • Founded 2019 • Startup • New • Venture round $56M · 2 yr ago • venBio Partners
Attralus is focused on advancing new solutions for amyloidosis therapy. The team has deep experience in Amyloid research and therapeutic development.
Scientific Advisory · Directors · decision-maker · no contact
James Testa · Executive Officer · decision-maker · no contact
Gregory Bell · Executive Officer · decision-maker · no contact
Glen Firestone · Executive Officer · decision-maker · no contact
Careers mailbox is known
Follow
···
rayzebio.com
rayzebio.com • San Diego, United States +1 offices • Drug Discovery • Biotechnology • 1001-5000 employees • Founded 2020 • Startup • New • Venture round $167.9M · 4 yr ago • Sofinnova Investments · venBio Partners
What We Do We are focused on creating precision radiopharmaceutical therapies (RPTs) that transform people’s lives.
Arvind Kush · Executive Officer · decision-maker · no contact
Aubrey Haddach · Executive Officer · decision-maker · no contact
Deborah Charych · Executive Officer · decision-maker · no contact
Ken Song · Executive Officer, Director · decision-maker · no contact
Careers mailbox is known
Follow
···
neurogastrx.com
neurogastrx.com • Woburn, United States • 201-500 employees • Founded 2017 • Startup • New • Venture round $60M · 5 yr ago • OrbiMed · venBio Partners
Neurogastrx, Inc.. Thank you for visiting the website for Neurogastrx, Inc. ("Company"), a privately held, late clinical-stage biopharmaceutical company formerly headquartered in Woburn, MA.
James O'mara · Executive Officer, Director · decision-maker · no contact
Paul Rogers · Executive Officer · decision-maker · no contact
James Detore · Executive Officer · decision-maker · no contact
Cyril De Colle · Executive Officer, Director · decision-maker · no contact
Careers mailbox is known
Follow
···
akerotx.com • South San Francisco • Health Care • Cardiometabolic Therapeutics • Likely startup • New • Apple Tree Partners · Atlas Venture +1
Akero Therapeutics is a clinical-stage company developing transformational therapies for people with metabolic dysfunction-associated steatohepatitis (MASH).
No named decision-maker yet.
No careers mailbox known
Sep 27 Moved to Greenhouse
Board re-checked 5 hours ago · 1 event in 14 days
Follow
···
histowiz.com
histowiz.com • Brooklyn, United States +1 offices • Science & Engineering • 11-50 employees • Founded 2012 • Startup • New • Venture round $345k · 10 yr ago • Y Combinator W16 · New York Angels +1 • Hiring now · 9 of 9
About Us Accelerating scientific research and discoveries through the automation of histology and digital pathology solutions. Enhancing the human condition is what fuels our passion.
Ke Cheng · Executive Officer, Director · decision-maker · no contact
Careers mailbox is known
Sep 26 9 roles in a day board at 9 Sep 25 Posted 9 roles Research Scientist - HistoWiz, Inc, Research Associate – Advanced Staining & Immunohistochemistry (IHC) - HistoWiz,
9 open +9 this week
Board re-checked 1 day ago · 11 events in 14 days
Follow
9 roles
···
axonis.us • Boston • Biotechnology • Startup • New • Lumira Ventures · venBio Partners
AXONIS Therapeutics, Inc. is advancing breakthrough discoveries to develop first-in-class therapies for neurological disorders.
No named decision-maker yet.
No careers mailbox known
Follow
···
precisionbiosciences.com
precisionbiosciences.com • Durham, United States • Clinical Trial Services (CRO) • Health Care • Startup • New • Venture round $88.1M · 8 yr ago • venBio Partners
ARCUS Genome Editing. At Precision BioSciences, we are using our novel ARCUS genome-editing technology to develop a new class of medicines designed to overcome and potentially cure hard-to-treat conditions, including rare genetic diseases.
Jeff Smith · Executive Officer · decision-maker · no contact
Abid Ansari · Executive Officer · decision-maker · no contact
Matthew Kane · Executive Officer, Director · decision-maker · no contact
Derek Jantz · Executive Officer, Director · decision-maker · no contact
Careers mailbox is known
Follow
···
insamo.com
insamo.com • Berkeley, United States • Biotechnology • 51-200 employees • Founded 2022 • Startup • New • Venture round $9.5M · 3 yr ago • Playground · venBio Partners
Insamo is a global biotechnology company pioneering the discovery of membrane-permeable and orally available cyclic-peptides with antibody-like binding affinity.
Glen Mcintyre · Executive Officer, Director · decision-maker · no contact
Toby Passioura · Executive Officer, Director · decision-maker · no contact
Timothy Craven · Executive Officer, Director · decision-maker · no contact
Matt Hershenson · Director · no contact
Careers mailbox is known
Follow
···
lyell.com
lyell.com • South San Francisco, United States +4 offices • Oncology Therapeutics • Cell & Gene Therapy • 51-200 employees • Startup • New • Foresite Capital · venBio Partners • Likely open · 3 of 8
Learn about Lyell and how we are building an industry-leading clinical-stage pipeline of CAR-T cell product candidates for cancer.
No named decision-maker yet.
Careers mailbox is known
Sep 26 Posted 8 roles Director, Clinical Science, Director or Senior Director, Investor Relations and Corporate Communications
8 open $241k stated pay, 8 roles
Board re-checked 1 day ago · 9 events in 14 days
Follow
8 roles
···
alumis.com
alumis.com • South San Francisco, United States • Sales & Marketing • Biotechnology • 11-50 employees • Founded 2021 • Startup • Venture round $40M · 2 yr ago • Foresite Capital · HBM Healthcare Investments +4
We are using a precision approach to develop therapies designed to transform the lives of patients with immune-mediated diseases.
June Lee · Executive Officer, Director · decision-maker · no contact
Roy Hardiman · Executive Officer · decision-maker · no contact
Jorn Drappa · Executive Officer · decision-maker · no contact
David Goldstein · Executive Officer · decision-maker · no contact
Careers mailbox is known
Sep 21 Closed a role Manager, Medical Congress & Events Management · Senior Manager, People & Culture Operations crossed 45 days open Sep 18 Added to the stack Microsoft Office Sep 17 Closed a role Senior Scientist, Drug Product Development Sep 15 Posted a role, closed 1 Manager, Medical Congress & Events Management
4 open $160k stated pay, 3 roles truth B 75 100% stale
Board re-checked 5 hours ago · 6 events in 14 days
Follow
4 roles
···